## MOH: Molina Healthcare, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 4.0% below STRENGTH zone (4.0-10.0%); PEG 2.54 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (44% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($156.58)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bearish (Bullish: 0, Bearish: 4)

**1. Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Shareholders to Inquire about Securities Investigation**
- Source: WRIC ABC 8News | 20251228T210813 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (NYSE: MOH) regarding corporate wrongdoing. The firm encourages shareholders who purchased Molina securities prior to February 5, 2025, and still hold them, to contact them for more information and to assist in the investigation. The investigation seeks to determine if Molina and its officers or directors engaged in misconduct.

**2. Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Shareholders to Inquire about Securities Investigation**
- Source: DC News Now | 20251228T160942 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. (NYSE: MOH) securities. The investigation focuses on whether Molina and its officers/directors engaged in corporate wrongdoing. Investors who bought Molina securities before February 5, 2025, and still hold them, are encouraged to contact the firm for more information.

**3. Molina Healthcare, Inc $MOH Shares Sold by Voya Investment Management LLC**
- Source: MarketBeat | 20251228T132351 | Bearish | Relevance: 100%
- Voya Investment Management LLC significantly reduced its stake in Molina Healthcare, Inc ($MOH) by 52.8% in Q3, selling 14,357 shares and retaining 12,857 shares valued at $2.46 million. This reduction comes as Molina reported Q3 EPS of $1.84, missing analyst estimates, despite revenue beating expectations. The company's stock currently holds an average "Hold" rating from analysts with an average price target of $196.33.

**4. Cwm LLC Purchases 59,690 Shares of Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20251228T090534 | Somewhat-Bearish | Relevance: 100%
- Cwm LLC significantly increased its stake in Molina Healthcare (NYSE:MOH) by 364.9%, acquiring 59,690 additional shares to own a total of 76,049 shares valued at approximately $14.55 million. This move comes as Molina Healthcare reported a quarterly EPS miss but an 11% revenue increase, with analysts maintaining a "Hold" rating and an average price target of $196.33 for the stock.

**5. Molina Healthcare, Inc $MOH Shares Purchased by Swedbank AB**
- Source: MarketBeat | 20251227T110828 | Somewhat-Bearish | Relevance: 100%
- Swedbank AB increased its holdings in Molina Healthcare, Inc (MOH) by 8.2% in the third quarter, acquiring an additional 8,416 shares to own a total of 110,592 shares valued at approximately $21.16 million. Despite institutional investors owning 98.5% of the stock, analysts have a "Hold" rating with an average price target of $196.33, after the company reported a significant quarterly EPS miss and provided lower-than-expected FY2025 guidance.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (9.4%): bears positioning against stock.
2. Long-term trend broken: trading 26.4% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.54 signals overvaluation risk, limited margin of safety. Forward P/E 10.1x attractive for 18% earnings growth. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.0B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.54 |
| Forward P/E | 10.1 |
| Current P/E | 12.0 |
| YoY Growth | 18.1% |
| EPS Direction | None |

### Technicals

MRS_20 stable at 4.0% (minimal 5-day change). Below STRENGTH zone by 0.0pp (needs >4.0% for momentum thesis). MRS_5 at 1.5% confirms short-term momentum alignment. AM_20 at 4.4% shows strong absolute momentum above own 20MA. Outperforming sector by 3.0pp, stock-specific strength. Below SMA200 (0.74x), long-term trend not supportive. MACD histogram positive (0.72), confirming momentum. Volume at 44% of 20MA suggests lack of conviction. OFD pattern: +MLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.99% (CS: 91) | Neutral |
| RSI_14 | 62.6 | Neutral |
| MACD Histogram | 0.72 | Bullish |
| vs SMA20 | 1.044x | Above |
| vs SMA50 | 1.065x | Above |
| vs SMA200 | 0.736x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $166.52
- **Stop Loss:** $156.58 (6.0% risk)
- **Target:** $176.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 138
- **Position Value:** $22,979.76
- **Portfolio %:** 22.98%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*